Clinical trial
Raloxifene in Preventing Breast Cancer in Premenopausal Women
NCT00019500 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019500 |
|---|---|
| Title | Raloxifene in Preventing Breast Cancer in Premenopausal Women |
| Official title | A Randomized Phase II Trial of Two Doses of Raloxifene in Pre-Menopausal Women at High Risk For Developing Invasive Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | raloxifene, evaluation of cancer risk factors |
| Start date | Dec 1, 1998 |
| Completion | Jun 1, 2005 |
| First posted | Jun 23, 2005 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: